Zydus Cadila gets USFDA nod to market generic cancer drug in US
newsdepo.com
The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.Zydus Cadila gets USFDA nod to market generic cancer drug in US
The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement. Read more